Your browser doesn't support javascript.
loading
Antitumor effects of recombinant antivascular protein ABRaA-VEGF121 combined with IL-12 gene therapy.
Ciomber, Agnieszka; Smagur, Andrzej; Mitrus, Iwona; Cichon, Tomasz; Smolarczyk, Ryszard; Sochanik, Aleksander; Szala, Stanislaw; Jarosz, Magdalena.
Affiliation
  • Ciomber A; Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101, Gliwice, Poland.
Arch Immunol Ther Exp (Warsz) ; 62(2): 161-8, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24220932
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Recombinant Fusion Proteins / CD4-Positive T-Lymphocytes / T-Lymphocytes, Regulatory / Interleukin-12 / CD8-Positive T-Lymphocytes / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Arch Immunol Ther Exp (Warsz) Year: 2014 Document type: Article Affiliation country: Poland Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Recombinant Fusion Proteins / CD4-Positive T-Lymphocytes / T-Lymphocytes, Regulatory / Interleukin-12 / CD8-Positive T-Lymphocytes / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Arch Immunol Ther Exp (Warsz) Year: 2014 Document type: Article Affiliation country: Poland Country of publication: Switzerland